DKP Critical Insights® Syndicated Reports

DKP has developed a series of syndicated reports to provide perspectives into the oncology and rare-disease environment. The reports are designed to help you inform short- and long-term strategies that will support market positioning of your portfolio, as well as ongoing patient access to care.

State Biosimilars and Biologic Substitution Legislation
  • Utilize an interactive map to identify biosimilar and biologic substitution legislation for each of the 50 states, DC, and Puerto Rico
  • Learn each state’s requirements for substituting a biosimilar with its reference product
  • This report helps inform your products short-term and long-term strategies in regards to positioning your portfolio in alignment with the FDA’s focus on cost reduction, which includes the uptake and utilization of biosimilars
Click here for more information
Questions?

We'd love to help you. Give us a call at (317) 873-0303.

Send us a message
  • This field is for validation purposes and should be left unchanged.